Literature DB >> 22457205

Mechanisms underlying decreased hepatic triacylglycerol and cholesterol by dietary bitter melon extract in the rat.

Gamarallage V K Senanayake1, Nobuhiro Fukuda, Shoko Nshizono, Yu-Ming Wang, Koji Nagao, Teruyoshi Yanagita, Masako Iwamoto, Hideaki Ohta.   

Abstract

In these studies, we focused on finding the mechanism(s) underlying the bitter melon (Momordica charantia L.) methanol fraction (MF)-dependent reduction in the concentration of hepatic triacylglycerol (TAG) and cholesterol in the rat. Rats were fed diets containing low (5 %) fat for 2 weeks (experiment 1), or low (5 %) and high (15 %) fat for a longer period of 8 weeks (experiment 2). MF was supplemented at 1 % level in both experiments. After feeding, rats were sacrificed, and their livers were prepared as slices and hepatocytes, followed by incubation with [1(2)-¹⁴C] acetate or [1-¹⁴C] oleic acid (18:1 n-6). Under these conditions, we found that rats fed diets containing MF, as compared to those without MF, showed: (1) no adverse effects on food intake and growth, (2) a decreased hepatic TAG and total cholesterol, irrespective of the difference in dietary fat level or feeding period, and (3) a decreased incorporation of [1(2)-(¹⁴C] acetate and [1-¹⁴C] oleic acid into TAG of liver slices and hepatocytes. MF-supplemented rats also showed no altered incorporation of labeled acetate into cholesterol and cholesterol ester, an increased fecal excretion of neutral steroids, but not of acidic steroids, and an enhanced mRNA abundance of carnitine palmitoylacyltransferase I, which is the rate-limiting enzyme for fatty acid oxidation. These results suggest that dietary MF decreases hepatic TAG synthesis while enhancing fatty acid oxidation, thereby reducing the concentration of hepatic TAG. The liver cholesterol-lowering effect of MF, however, is probably mediated through an increased fecal excretion of neutral steroids, without an effect on cholesterogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457205     DOI: 10.1007/s11745-012-3667-0

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  31 in total

1.  Preventive effect of sesquiterpenes from bay leaf on blood ethanol elevation in ethanol-loaded rat: structure requirement and suppression of gastric emptying.

Authors:  H Matsuda; H Shimoda; T Uemura; M Yoshikawa
Journal:  Bioorg Med Chem Lett       Date:  1999-09-20       Impact factor: 2.823

2.  Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies.

Authors: 
Journal:  J Nutr       Date:  1977-07       Impact factor: 4.798

Review 3.  Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.

Authors:  Michael B Krawinkel; Gudrun B Keding
Journal:  Nutr Rev       Date:  2006-07       Impact factor: 7.110

4.  Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet.

Authors:  Qixuan Chen; Laureen L Y Chan; Edmund T S Li
Journal:  J Nutr       Date:  2003-04       Impact factor: 4.798

5.  Limitations of acetate as a substrate for measuring cholesterol synthesis in liver.

Authors:  J M Dietschy; J D McGarry
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

6.  Studies on the response of cholesterol biogenesis in feeding in rats: evidence against the existence of diurnal rhythms.

Authors:  R Fears; B Morgan
Journal:  Biochem J       Date:  1976-07-15       Impact factor: 3.857

Review 7.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

Review 8.  The biological action of saponins in animal systems: a review.

Authors:  George Francis; Zohar Kerem; Harinder P S Makkar; Klaus Becker
Journal:  Br J Nutr       Date:  2002-12       Impact factor: 3.718

9.  Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).

Authors:  A Raman; C Lau
Journal:  Phytomedicine       Date:  1996-03       Impact factor: 5.340

10.  Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction.

Authors:  Yuichi Oishi; Tatsuaki Sakamoto; Haruhide Udagawa; Hironobu Taniguchi; Kazuo Kobayashi-Hattori; Yoshio Ozawa; Toshichika Takita
Journal:  Biosci Biotechnol Biochem       Date:  2007-03-07       Impact factor: 2.043

View more
  6 in total

Review 1.  Cardiovascular disease risk reduction in diabetes through conventional and natural approaches.

Authors:  William M Schultz; Elliot N Mahlof; Devinder S Dhindsa; Tina Varghese; Robert E Heinl; Hannah C Cai; Pratik B Sandesara; Danny J Eapen; Laurence S Sperling
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

Review 2.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

3.  Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation.

Authors:  Yanmei Zeng; Meiping Guan; Chenzhong Li; Lingling Xu; Zhongji Zheng; Jimin Li; Yaoming Xue
Journal:  Lipids Health Dis       Date:  2018-11-06       Impact factor: 3.876

Review 4.  The Role of Momordica charantia in Resisting Obesity.

Authors:  Meiqi Fan; Eun-Kyung Kim; Young-Jin Choi; Yujiao Tang; Sang-Ho Moon
Journal:  Int J Environ Res Public Health       Date:  2019-09-04       Impact factor: 3.390

5.  Saponins from bitter melon reduce lipid accumulation via induction of autophagy in C. elegans and HepG2 cell line.

Authors:  Juan Bai; Ying Zhu; Linzhao He; Jinfu Zhang; Jie Li; Ruirong Pan; Jiayan Zhang; Yansheng Zhao; Lin Cui; Haina Lu; Ya Jiang; Xiang Xiao
Journal:  Curr Res Food Sci       Date:  2022-07-22

6.  Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways.

Authors:  Chia-Jung Li; Shih-Fang Tsang; Chun-Hao Tsai; Hsin-Yi Tsai; Jong-Ho Chyuan; Hsue-Yin Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-04       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.